| COMIRNATY Omicron XBB.1.5 10 mcg injection EU/1/20/1528/024 |
Tozinameran |
BioNTech Manufacturing GmbH |
— |
| COMIRNATY Omicron XBB.1.5 10 micrograms/dose concentrate for dispersion for injection children 5 to 11 years EU/1/20/1528/021 |
Tozinameran |
BioNTech Manufacturing GmbH |
— |
| COMIRNATY Omicron XBB.1.5 10 micrograms/dose dispersion for injection children 5 to 11 years EU/1/20/1528/022 |
Tozinameran |
BioNTech Manufacturing GmbH |
— |
| COMIRNATY Omicron XBB.1.5 10 micrograms/dose dispersion for injection children 5 to 11 years EU/1/20/1528/023 |
Tozinameran |
BioNTech Manufacturing GmbH |
— |
| COMIRNATY Omicron XBB.1.5 3 micrograms/dose concentrate for dispersion for injection children 6 months to 4 years EU/1/20/1528/026 |
Raxtozinameran |
BioNTech Manufacturing GmbH |
— |
| COMIRNATY Omicron XBB.1.5 30 micrograms/dose dispersion for injection adults and adolescents from 12 years EU/1/20/1528/018 |
Tozinameran |
BioNTech Manufacturing GmbH |
— |
| COMIRNATY Omicron XBB.1.5 30 micrograms/dose dispersion for injection adults and adolescents from 12 years EU/1/20/1528/019 |
Tozinameran |
BioNTech Manufacturing GmbH |
— |
| COMIRNATY Omicron XBB.1.5 30 micrograms/dose dispersion for injection adults and adolescents from 12 years EU/1/20/1528/020 |
Tozinameran |
BioNTech Manufacturing GmbH |
— |
| Competact 15 mg/850 mg film-coated tablets EU/1/06/354/005-010 |
Pioglitazone, Metformin Hydrochloride |
CHEPLAPHARM Arzneimittel GmbH |
— |
| COMTESS 200 mg Film-coated tablet EU/1/98/082/001 |
|
Orion Corporation |
— |
| COMTESS 200 mg Film-coated tablet EU/1/98/082/002 |
|
Orion Corporation |
— |
| COMTESS 200 mg Film-coated tablet EU/1/98/082/003 |
|
Orion Corporation |
— |
| CONBRIZA 20 mg Film-coated tablet EU/1/09/511/1-4 |
Bazedoxifene |
Pfizer Europe MA EEIG |
— |
| Conexxence 60 mg solution for injection in pre-filled syringe EU/1/25/1954/01 |
Denosumab |
Fresenius Kabi Deutschland GmbH |
— |
| Constella 290 micrograms hard capsules EU/1/12/801/001-004 |
Linaclotide |
AbbVie Deutschland GmbH & Co. KG |
— |
| CONTROLOC Control 20 mg Gastro-resistant tablet EU/1/09/515/001-004 |
Pantoprazole sodium sesquihydrate |
Takeda GmbH |
— |
| Copalia 10 mg/160 mg film-coated tablets EU/1/06/372/017-024 |
Amlodipine besilate, Valsartan |
Novartis Europharm Limited |
— |
| Copalia 5 mg/160 mg film-coated tablets EU/1/06/372/009-016 |
Amlodipine besilate, Valsartan |
Novartis Europharm Limited |
— |
| Copalia 5 mg/80 mg film-coated tablets EU/1/06/372/001-008 |
Amlodipine besilate, Valsartan |
Novartis Europharm Limited |
— |
| Copalia HCT 10 mg/160 mg/12.5 mg film-coated tablets EU/1/09/575/13-24 |
Hydrochlorothiazide, Valsartan, Amlodipine besilate |
Novartis Europharm Limited |
— |
| Copalia HCT 10 mg/160 mg/25 mg film-coated tablets EU/1/09/575/37-48 |
Hydrochlorothiazide, Valsartan, Amlodipine besilate |
Novartis Europharm Limited |
— |
| Copalia HCT 10 mg/320 mg/25 mg film-coated tablets EU/1/09/575/49-60 |
Valsartan, Hydrochlorothiazide, Amlodipine besilate |
Novartis Europharm Limited |
— |
| Copalia HCT 5 mg/160 mg/12.5 mg film-coated tablets EU/1/09/575/1-12 |
Amlodipine besilate, Hydrochlorothiazide, Valsartan |
Novartis Europharm Limited |
— |
| Copalia HCT 5 mg/160 mg/25 mg film-coated tablets EU/1/09/575/25-36 |
Amlodipine besilate, Hydrochlorothiazide, Valsartan |
Novartis Europharm Limited |
— |
| Corbilta 100 mg/25mg/200 mg film coated tablets EU/1/13/859/012-017 |
Carbidopa monohydrate, Entacapone, Levodopa |
Orion Corporation |
— |
| Corbilta 125 mg/31.25 mg/200 mg film-coated tablets EU/1/13/859/018-022 |
Entacapone, Carbidopa monohydrate, Levodopa |
Orion Corporation |
— |
| Corbilta 150 mg/37.5 mg/200 mg film-coated tablets EU/1/13/859/023-028 |
Levodopa, Carbidopa monohydrate, Entacapone |
Orion Corporation |
— |
| Corbilta 175 mg/43.75 mg/200 mg film-coated tablets EU/1/13/859/029-033 |
Entacapone, Carbidopa monohydrate, Levodopa |
Orion Corporation |
— |
| Corbilta 200 mg/50 mg/200 mg film-coated tablets EU/1/13/859/034-038 |
Entacapone, Carbidopa monohydrate, Levodopa |
Orion Corporation |
— |
| Corbilta 50 mg/12.5 mg/200 mg film-coated tablets EU/1/13/859/001-006 |
Carbidopa monohydrate, Entacapone, Levodopa |
Orion Corporation |
— |
| Corbilta 75 mg/18.75 mg/200 mg film-coated tablets EU/1/13/859/007-011 |
Entacapone, Carbidopa monohydrate, Levodopa |
Orion Corporation |
— |
| Corlentor 5 mg film-coated tablets EU/1/05/317/1-7 |
Ivabradine |
Les Laboratoires Servier |
— |
| Corlentor 7.5 mg film-coated tablets EU/1/05/317/8-14 |
Ivabradine |
Les Laboratoires Servier |
Not marketed |
| Corsodyl Freshmint 0.2% w/v Mouthwash PA0678/002/005 |
Chlorhexidine digluconate (as chlorhexidine digluconate solution (20% w/v) ph.eur. |
Haleon Ireland Limited |
Not marketed |
| Cosentyx 150 mg Powder for solution for injection EU/1/14/980/001 |
Secukinumab |
Novartis Europharm Limited |
— |
| Cosentyx 150 mg Solution for injection pre-filled pen EU/1/14/980/004-005 |
Secukinumab |
Novartis Europharm Limited |
— |
| Cosentyx 150 mg Solution for injection pre-filled syringe EU/1/14/980/002-003 |
Secukinumab |
Novartis Europharm Limited |
— |
| Cosentyx 300 mg Solution for injection in pre-filled pen EU/1/14/980/10-011 |
Secukinumab |
Novartis Europharm Limited |
— |
| Cosentyx 300 mg Solution for injection in pre-filled syringe EU/1/14/980/008-009 |
Secukinumab |
Novartis Europharm Limited |
— |
| Cosentyx 75 mg Solution for injection pre-filled syringe EU/1/14/980/012-013 |
Secukinumab |
Novartis Europharm Limited |
— |
| Cotellic 20 mg film-coated tablets EU/1/15/1048/001 |
Cobimetinib hemifumarate |
Roche Registration GmbH |
— |
| CRESEMBA 100 mg hard capsules EU/1/15/1036/002 |
Isavuconazonium sulfate |
Basilea Pharmaceutica Deutschland GmbH |
— |
| CRESEMBA 200 mg powder for concentrate for solution for infusion EU/1/15/1036/001 |
Isavuconazonium sulfate |
Basilea Pharmaceutica Deutschland GmbH |
— |
| CRESEMBA 40 mg hard capsules EU/1/15/1036/003 |
Isavuconazonium sulfate |
Basilea Pharmaceutica Deutschland GmbH |
— |
| CRYSVITA 10 mg solution for injection EU/1/17/1262/001 |
Recombinant human igg1 monoclonal antibody to fibroblast growth factor 23 |
Kyowa Kirin Holdings B.V. |
— |
| CRYSVITA 20 mg solution for injection EU/1/17/1262/002 |
Recombinant human igg1 monoclonal antibody to fibroblast growth factor 23 |
Kyowa Kirin Holdings B.V. |
— |
| CRYSVITA 30 mg solution for injection EU/1/17/1262/003 |
Recombinant human igg1 monoclonal antibody to fibroblast growth factor 23 |
Kyowa Kirin Holdings B.V. |
— |
| Cubicin 350 mg powder for solution for injection or infusion EU/1/05/328/001 |
Daptomycin |
Merck Sharp & Dohme BV |
— |
| Cubicin 500 mg powder for solution for injection or infusion EU/1/05/328/002 |
Daptomycin |
Merck Sharp & Dohme BV |
— |
| Cufence EU/1/19/1365/002 |
Trientine tetrahydrochloride |
Univar B.V |
— |